Literature DB >> 35550478

Examining the Multilevel Barriers to Pharmacy-Based HIV Prevention and Treatment Services.

Natalie D Crawford1, Crystal F Lewis, Ronnie Moore2, Glen Pietradoni3, Paul Weidle4.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35550478      PMCID： PMC9560970          DOI： 10.1097/OLQ.0000000000001643

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   3.868


× No keyword cloud information.
  37 in total

1.  Pharmacists' strategies for promoting medication adherence among patients with HIV.

Authors:  Jennifer Kibicho; Jill Owczarzak
Journal:  J Am Pharm Assoc (2003)       Date:  2011 Nov-Dec

2.  Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men.

Authors:  Natalie D Crawford; Dorie Josma; Joseph Morris; Roderick Hopkins; Henry N Young
Journal:  J Am Pharm Assoc (2003)       Date:  2020-01-30

Review 3.  Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses.

Authors:  Patrick S Sullivan; Anna Satcher Johnson; Elizabeth S Pembleton; Rob Stephenson; Amy C Justice; Keri N Althoff; Heather Bradley; Amanda D Castel; Alexandra M Oster; Eli S Rosenberg; Kenneth H Mayer; Chris Beyrer
Journal:  Lancet       Date:  2021-02-19       Impact factor: 79.321

4.  Evaluation of Pharmacy-Based HIV Testing in a High-Risk New York City Community.

Authors:  Silvia Amesty; Natalie D Crawford; Vijay Nandi; Rafael Perez-Figueroa; Alexis Rivera; Madeline Sutton; Paul J Weidle; Leigh Willis; Dawn K Smith; Carolyn Hernandez; Katherine Harripersaud; Crystal Fuller Lewis
Journal:  AIDS Patient Care STDS       Date:  2015-08       Impact factor: 5.078

5.  HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection.

Authors:  Paul J Weidle; Shirley Lecher; Linda W Botts; LaDawna Jones; David H Spach; Jorge Alvarez; Rhondette Jones; Vasavi Thomas
Journal:  J Am Pharm Assoc (2003)       Date:  2014 Sep-Oct

6.  Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness.

Authors:  Michael E Klepser; Donald G Klepser; Allison M Dering-Anderson; Jacqueline A Morse; Jaclyn K Smith; Stephanie A Klepser
Journal:  J Am Pharm Assoc (2003)       Date:  2016-01

Review 7.  Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States.

Authors:  Natalie C Weber; Michael E Klepser; Julie M Akers; Donald G Klepser; Alex J Adams
Journal:  Expert Rev Mol Diagn       Date:  2015-11-27       Impact factor: 5.225

8.  Developing a Web-Based Geolocated Directory of HIV Pre-Exposure Prophylaxis-Providing Clinics: The PrEP Locator Protocol and Operating Procedures.

Authors:  Aaron J Siegler; Susan Wirtz; Shannon Weber; Patrick S Sullivan
Journal:  JMIR Public Health Surveill       Date:  2017-09-06

9.  Utilization of community pharmacy space to enhance privacy: a qualitative study.

Authors:  H Laetitia Hattingh; Lynne Emmerton; Pascale Ng Cheong Tin; Catherine Green
Journal:  Health Expect       Date:  2015-08-31       Impact factor: 3.377

Review 10.  Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.

Authors:  Kenneth H Mayer; Allison Agwu; David Malebranche
Journal:  Adv Ther       Date:  2020-03-30       Impact factor: 3.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.